Purchases and Sales Made in Q1 2024 in Eye Point Pharmaceuticals, Inc. (EYPT)
This table provides information about the institutional ownership of Eye Point Pharmaceuticals, Inc. (EYPT) during Q1 2024. The information is specifically focused on institutions that hold shares of EyePoint Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Dec 26, 2024
Q1 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-344K- 92.57% |
$6.86M - $10.2M
|
27.6K
$168K
|
|
|
May 15, 2024
Q1 2024
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-367K- 99.72% |
$7.32M - $10.9M
|
1.05K
$6.39K
|
|
|
May 15, 2024
Q1 2024
|
Essex Woodlands Management, Inc.
The Woodlands, TX |
SELL
|
- |
-786K- 33.63% |
$15.7M - $23.4M
|
1.55M
$9.46M
|
|
|
May 15, 2024
Q1 2024
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-863K- 56.17% |
$17.2M - $25.6M
|
673K
$4.11M
|
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-911K- 40.42% |
$18.1M - $27.1M
|
1.34M
$8.19M
|
|
|
May 13, 2024
Q1 2024
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-1.25M- 26.97% |
$24.9M - $37.2M
|
3.39M
$20.7M
|